Two-time tongue cancer survivor: Why I support research at UT MD Anderson
Sometimes, the most meaningful breakthroughs in medicine aren’t about saving your life — they’re about saving your quality of life. That was certainly the case for me when facing my second possible recurrence of tongue cancer in just six years in the spring of 2025.
By then, I’d already undergone two oral surgeries near my home in Pennsylvania. Each one came with its own set of frustrations...
Metastatic melanoma survivor trusts UT MD Anderson’s expertise and research
Joe Eastin was first diagnosed with melanoma on his left ear in 2012. The Dallas resident had surgery at home to treat the cancer and two...
Stage 4 cervical cancer survivor thankful for immunotherapy clinical trial
Looking back, Paulette Burkhart believes the fatigue she began experiencing in 2023 was not because she needed to take vitamins or get more...
Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’
Normally, leukemia is a disease that strikes old people and babies. So, when I was diagnosed with chronic myeloid leukemia in November 2022, I was shocked. There is zero history of cancer in my family. At the time, I was only 36.
I was even more shocked to learn that I had not just one form of leukemia, but two: chronic myeloid leukemia and acute myeloid leukemia.  ...
Immunotherapy and colorectal cancer: Where we are and what’s ahead
The immune system defends the body from viruses and bacteria. But it’s not as successful in killing cancer on its own. Immune checkpoint inhibitors...
Total neoadjuvant therapy: A new era for patients with locally advanced rectal cancer
When rectal cancer advances to involve nearby lymph nodes but hasn’t spread to other areas of the body, it’s considered to be locally advanced...
Understanding the different types of lymphoma
You may have already heard about non-Hodgkin lymphoma. But are there other kinds of lymphoma? What makes each one unique? And, are some symptoms...
Stage IV lung cancer survivor: ‘Go straight to UT MD Anderson’
By the time I was diagnosed with stage IV lung cancer in the fall of 2024, it had spread all ...
Stage IV melanoma survivor: An immunotherapy clinical trial saved my life
I’ve always had very fair skin and light-colored eyes. Over the years, I’ve had plenty of sun exposure, too — first as a geophysicist working...
CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission
When JC Cox was diagnosed with a type of non-Hodgkin lymphoma called follicular lymphoma in 2006, the now-retired HVAC technician sought treatment...